CGBio obtains the third permit for cervical cage Novomax-Fusion in Japan, … following the permits received from Europe and Australia Obtaining a PMDA permit in Japan, following the CE certification in Europe and the TGA permit in Australia… Accelerating overseas exports Achieving… 2023-07-11 cgbio
CGBio set to develop next-generation patient-customized artificial bones with an American research institute in regenerative medicine Development of high-functional 3D implants with increased content of BGS-7, new high-strength bioactive ceramic materials Collaboration with Wake Forest Institute of Regenerative… 2023-07-03 cgbio
CGBio launches HA filler Giselleligne Signature 2 in China Taking the first step into the market following the signing of a KRW70 billion supply contract Official launch following the signing of a KRW70 billion supply contract in March, speeding up its market entry into China Contains lidocaine,… 2023-06-23 cgbio
CGBio showcases next-generation spine solutions at one of the world’s top three spine conferences Global Spine Congress 2023, one of the world’s top three academic conferences that gather renowned spine specialists from all around the world… 2023-06-19 cgbio
CGBio signs an MOU with CIMED, one of the five leading pharmaceutical companies in Brazil, for the supply of calcium filler FACETEM Taking on the Brazilian market by signing a strategic business agreement with CIMED, one of the five leading pharmaceutical companies in Brazil… 2023-06-12 cgbio
CGBio attends international spine conference “Spine Week 2023”… Showcasing quality alternative bone substitutes and PSI platform CGBio attends the world’s largest spine conference, Spine Week 2023 with an independent booth Presenting a portfolio of bone and spine solutions… 2023-05-24 cgbio
CGBio Establishes US Corporation ‘CG MedTech’… Full-scale Launch of Total Regenerative Medicine Solution in North America 100% Capital investment from CGBio… Serving as a bridge for full-scale overseas expansion alongside the corporation based in Indonesia Skin and bone… 2023-04-27 cgbio
CGBio Sales for 2022 Reach KRW 129.7 Billion… Growth Led by the ‘Cosmetic Surgery Division’ Sales increased by 37% and operating profits increased by 13% YoY as the company posts its highest sales ever ‘Noticeably’ steep growth… 2023-04-26 cgbio
CGBio Smart Factory obtains the BGMP certification… accelerating its entry into the South American market Speeding up the business expansion for HA filler GISELLELIGNE and calcium filler Facestem in South America S-Campus has a production capability for… 2023-04-17 cgbio
CGBio Participating in the Global Beauty and Anti-aging Academic Conference ‘AMWC’ and Concludes a Supplier Agreement for Calcium Filler ‘Facetem’ Worth 16.5 Billion Won Aiming directly to expand into the European market by participating in the world’s largest anti-aging academic conference and through export agreements Calcium… 2023-04-04 cgbio
